Cochlear Limited (Cochlear) is an Australia-based company, which operates in the implantable hearing device industry.
The Company operates in three geographic segments: Americas, Europe and Asia Pacific. Cochlear runs manufacturing operations in Australia and Sweden.
During the fiscal year ended June 30, 2010 (fiscal 2010), the Company launched the Cochlear Nucleus 5 System and the Cochlear Baha System. Nucleus 5 is accessed in countries like Australia, Hong Kong, India, Malaysia, New Zealand, Singapore and Thailand. The cochlear implant manufacturing technicians have improved mechanisation, which has supported the delivery of the Nucleus 5.
The Cochlear Nucleus 5 System provides a hearing solution to deliver hearing outcomes for both adults and children. The Cochlear Hybrid System is an integrated electro-acoustic hybrid hearing solution. The System provides a hearing solution for people with severe to profound high-frequency hearing loss.
Latest Media Releases
Latest News
Stock Watch /
by -
3 days ago
19 Feb 2020 - Fund Manager Chris Pedersen provides an overview of results so far.
Market Reports /
by Rachael Jones -
4 days ago
18 Feb 2020 - The ASX closed 0.2% lower today failing to gain momentum after dropping at the open. Shares in the Monadelphous Group (ASX:MND) rose today after they released their r…
Company News /
by Rachael Jones -
4 days ago
18 Feb 2020 - Hearing implant manufacturer Cochlear's (ASX:COH) reported net profit increased by 23 per cent to $157.7 million and includes $25.0 million in non-cash after-tax gain…
Company News /
by Rachael Jones -
11 days ago
11 Feb 2020 - Medical device company Cochlear (ASX:COH) is reducing the guidance outlook for FY20 from $290-300 million to $270-290 million.
Market Reports /
by Rachael Jones -
2 months ago
10 Dec 2019 - It has been a rollercoaster day of trade for the ASX. The local bourse managed to close 0.3% lower. Companies to lose the most ground were Avita Medical (ASX:AVH), Me…
Stock Watch /
by -
3 months ago
12 Nov 2019 - Burman Invest Portfolio Manager Julia Lee discusses CSL, ResMed and Cochlear.
Stock Watch /
by -
5 months ago
16 Sep 2019 - Fairmont Equities Managing Director Michael Gable takes a technical look at Cochlear, Corporate Travel Management, Jumbo Interactive and Technology One.
Stock Watch /
by -
5 months ago
03 Sep 2019 - Burman Invest Portfolio Manager Julia Lee talks about the inversion of the yield curve and how to invest in a falling interest rate environment.
Market Reports /
by Rachael Jones -
6 months ago
19 Aug 2019 - The ASX shot up at the open following on from positive leads from Wall St and is now tracking 0.8% higher at noon. Construction firm Lendlease (ASX:LLC) saw their sha…
Market Reports /
by Jessica Amir -
6 months ago
16 Aug 2019 - Aussie shares lose 2.8% this week, on the US yield “2-10 inversion”, despite stronger than expected local and US economic news. Baby Bunting (ASX:BBN) results beat ex…
Company News /
by Rachael Jones -
6 months ago
16 Aug 2019 - Cochlear (ASX:COH) delivered net profit of $276.7 million, an increase of 13 per cent on FY18, which includes $10.8 million in non-cash net gains from the revaluation…
Stock Watch /
by -
6 months ago
12 Aug 2019 - Fairmont Equities Managing Director Michael Gable takes a technical look at the S&P 500, WiseTech Global (ASX:WTC), Cochlear (ASX:COH) and the A2 Milk Company (ASX:A2…
Company News /
by Anna Napoli -
8 months ago
17 Jun 2019 - Cochlear (ASX:COH) has today announced that it has received US Food and Drug Administration approval for its new Nucleus Profile Plus Series implant.
Market Reports /
by Katrina Bullock -
10 months ago
17 Apr 2019 - The ASX opened higher this morning following positive leads from the US to close 0.3 per cent lower. Only Communications and Financials managed to make ground today. …
Market Reports /
by Katrina Bullock -
10 months ago
17 Apr 2019 - The ASX200 opened higher following positive leads from Wall Street and is tracking 0.1% lower at noon. Most of the sectors are in the red. Nickel Mines (ASX:NIC) are …
Market Reports /
by Jessica Amir -
10 months ago
16 Apr 2019 - Eclipx Group (ASX:ECX) shares hit 4-week high as Credit Suisse increases ownership, Cochlear (ASX:COH) launches implant that doesn't need to be removed before MRI, Bl…
Market Reports /
by Jessica Amir -
10 months ago
16 Apr 2019 - Cochlear (ASX:COH) gains 6% on launching implant that doesn't need to be removed before MRI scans. Citi ups Ramsay Health Care’s (ASX:RHC) PT to $67 after meeting EU …
Company News /
by Anna Napoli -
10 months ago
16 Apr 2019 - Cochlear (ASX:COH) has today announced the launch of the Nucleus Profile Plus Series cochlear implant.
Company News /
by Rachael Jones -
11 months ago
08 Mar 2019 - Hearing implant manufacturer Cochlear (ASX:COH) is excited the UK has opened up the criteria for health professionals to decide who has implants on the National Healt…
Company News /
by Anna Napoli -
A year ago
19 Feb 2019 - Cochlear (ASX:COH) has announced its half year results for financial year 2019 with reported net profit rising 16 per cent to $128.6m, compared to the same time last …
Market Reports /
by Jessica Amir -
A year ago
13 Nov 2018 - Market Wrap. Iron ore & oil slip. Business confidence disappoints. Orocobre (ASX:ORE) up 3.5% on a brighter outlook. Westpac (ASX:WBC) loses a month of gains. NEXTDC …
Company News /
by Anna Napoli -
A year ago
13 Nov 2018 - Hearing device company, Cochlear, (ASX:COH) has invested €13 million in Nyxoah (SA).
Market Reports /
by Katrina Bullock -
A year ago
09 Nov 2018 - Local bourse ended the session 0.1 per cent down, Energy leading the drag, followed by the Tech and Consumer Discretionary sectors. Shares in property major, Lendleas…
Company News /
by Anna Napoli -
A year ago
09 Nov 2018 - Hearing device manufacturer Cochlear (ASX:COH) has signed a new agreement with audio solutions company, GN.
